The In Vitro Migration Capacity of Human Bone Marrow Mesenchymal Stem Cells: Comparison of Chemokine and Growth Factor Chemotactic Activities

By Adriana López Ponte, E. Marais, N. Gallay, A. Langonné, B. Delorme, O. Hérault, P. Charbord, J. Domenech. Stem Cells, 2007

983 citations recorded by the source corpus.

Subfields: Genetics, Hematology, Oncology

View Paper: https://www.semanticscholar.org/paper/a689ee6d6508ecf5b25deee3c23788aa57f5af73

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. A. Caplan
2. J. Karp
3. Grace Sock Leng Teo
4. Aline M. Betancourt
5. L. Meirelles
6. Ruth S. Waterman
7. Suzanne L. Tomchuck
8. Sarah L. Henkle

In Hematology

1. Aline M. Betancourt
2. Ruth S. Waterman
3. A. Caplan
4. Suzanne L. Tomchuck
5. Sarah L. Henkle

In Oncology

1. A. Caplan

Citations in the corpus

• Mechanisms involved in the therapeutic properties of mesenchymal stem cells. (2009, background): “Chemotaxis assays show that cultured MSCs migrate toward different growth factors and chemokines in a dose-dependent fashion in vitro, and that chemokine-driven migration is stimulated by the pro-inflammatory cytokine tumor necrosis factor (TNF)-a [47], which indicates that chemoattraction can direc”
• Mesenchymal stem cell homing: the devil is in the details. (2009, positive): “…that mediate MSC homing to specific sites, chemokines released from tissue or endothelial cells may promote activation of adhesion ligands, transendothelial migration, chemotaxis, and/or subsequent retention in surrounding tissue (Belema-Bedada et al., 2008; Hordijk, 2003; Ponte et al., 2007).”
• A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype (2010, background): “taking into consideration a related report stating that CCL5 (RANTES) driven hMSC migration was highly induced by pretreatment of the hMSCs with TNFa [39].”